Results 241 to 250 of about 2,029,665 (367)

RADIOFREQUENCY ABLATION OF THE PREVALENCE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PERSPECTIVE OF HUMAN SCIENCES

, 1970
Mário Fabrício Fleury Rosa, Suélia de Siqueira Rodrigues   +1 more
openalex   +2 more sources

Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. [PDF]

, 1984
Anne Dejean, P. Sonigo, Simon Wain‐Hobson, Pierre Tiollais   +3 more
openalex   +1 more source

WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma

Advanced Science, EarlyView.
This study reveals a new mechanism by which PDIA3P1 regulates the progression of esophageal squamous cell carcinoma (ESCC). PDIA3P1 upregulates the expression of GLUT1 and HK2, promoting glycolysis and lactate production. Lactate upregulates the lactylation level of histone H4K8 and activates the transcription of target gene BMP7, ultimately ...
Tao Huang, Qi You, Jiawei Liu, Xuguang Shen, Dengjun Huang, Xinlu Tao, Zhijie He, Chengwei Wu, Xinran Xi, Shouqiang Yu, Feng Liu, Zhihao Wu, Wenjun Mao, Shaojin Zhu   +13 more
wiley   +1 more source

Limitations of Radiographic Response Assessments of Systemic Therapy for Advanced Hepatocellular Carcinoma. [PDF]

JCO Precis Oncol
Lau-Min KS, Franses JW.
europepmc   +1 more source

Hepatocellular carcinoma, hepatitis B and measles

, 1979
G H Rée
openalex   +1 more source

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections [PDF]

, 1989
Brent E. Korba, Frances V. Wells, B. H. Baldwin, Paul J. Côté, Bud C. Tennant, Hans Pópper, John L. Gerin   +6 more
openalex   +1 more source

Exosomal CCT6A Secreted by Cancer‐Associated Fibroblasts Interacts with β‐Catenin to Enhance Chemoresistance and Tumorigenesis in Gastric Cancer

Advanced Science, EarlyView.
Here, it is revealed that CAF‐secreted exosomal CCT6A enhances stemness, chemoresistance, and glycolysis in GC via the β‐catenin/c‐Myc/DDIT4‐TXNIP axis. Furthermore, CCT6P1, a pseudogene of CCT6A, is identified as upregulating CCT6A by competitively binding miR‐922, while c‐Myc transcriptionally activates both CCT6P1 and CCT6A.
Hui Sun, Tianqi Zhang, Xiaoyan Zhang, Yingxue Liu, Xu Wang, Xin Wang, Cong Tan, Shujuan Ni, Weiwei Weng, Meng Zhang, Lei Wang, Dan Huang, Xiaoyu Wang, Wenfeng Wang, Weiqi Sheng, Mi‐die Xu   +15 more
wiley   +1 more source

Platelets in Hepatocellular Carcinoma-From Pathogenesis to Targeted Therapy. [PDF]

Cancers (Basel)
Kluz N, Grabowska H, Chmiel P, Rynkiewicz K, Skrobucha A, Wysokińska E, Szymański Ł, Wysocki PT, Semeniuk-Wojtaś A, Kraj L.   +9 more
europepmc   +1 more source

Splenoportographic Findings of Hepatocellular Carcinoma

, 1978
Atsushi Toyonaga, T Satomi, Masatake Yasumoto, S. Kuratomi, Hisaaki KAJI, Yoshikazu Nagasaki, T. Fujimi, Ei Sasaki, Kazuo Fukuda, Kyuichi Tanikawa, Kazuyoshi Sakamoto   +10 more
openalex   +2 more sources

Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study

Advanced Science, EarlyView.
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou, Jinling Jiang, Liting Guo, Wenqi Xi, Junwei Wu, Qu Cai, Jun Ji, Feng Qi, Jun Zhang   +8 more
wiley   +1 more source